Clinical trial
NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to…
NCT00089505 · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Other · Completed
Key facts
| NCT number | NCT00089505 |
|---|---|
| Title | NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission |
| Official title | Optimal Combination Therapy After Nevirapine Exposure |
| Acronym | OCTANE |
| Lead sponsor | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Emtricitabine, Emtricitabine/Tenofovir disoproxil fumarate, Lopinavir/Ritonavir, Nevirapine, Tenofovir disoproxil fumarate |
| Enrollment | 745 |
| Start date | Nov 1, 2006 |
| Primary completion | Aug 1, 2010 |
| Completion | Feb 1, 2011 |
| First posted | Aug 6, 2004 |
| Last update posted | Oct 12, 2018 |
| Countries | Botswana, Kenya, Malawi, South Africa, Uganda, Zambia, Zimbabwe |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: